30 Technology
  • Company
    • The Thirty Group
    • Board of directors
    • 30 Ecosystem
  • Technology
  • Research
    • 30 Woundcare
    • 30 Respiratory
    • 30 Therapeutics
    • 30 Pharma
    • 30 Dermatology
    • 30 Animal Health
  • News & Publications
  • Contact
Select Page

Sitemap

Authors

  • 30 Technology

Pages

  • Company
    • Board of directors
    • Collaborators
    • The Thirty Group
  • Contact
  • Cookies
  • Data Protection
  • Home
  • News & Publications
  • Privacy Policy
  • Research
    • Animal Health
    • Dermatology
    • Pharma
    • Respiratory
    • Therapeutics
    • Woundcare
  • Technology

Sitemap

  • News

    • MORNINGSIDE VENTURES INVESTS IN THIRTY HOLDINGS
    • A NEW NAME FOR A NEW ERA
    • BREAKTHROUGH TECHNOLOGY THAT DOUBLES HEALING RATE OF CHRONIC INFECTED DIABETES-RELATED ULCERS
    • BREAKTHROUGH TECHNOLOGY
    • US AND EU PATENTS GRANTED
    • ANTIMICROBIAL EFFECTIVENESS
    • PILOT STUDY SUPPORT FOR CHILDREN IN AFRICA

30 TECHNOLOGY is developing and defining new models of care to treat many serious medical conditions by enhancing the body’s healing and defence mechanisms.

30 TECHNOLOGY Therapeutic Nitric Oxide

  • Company
  • Technology
  • News & Publications
  • Privacy Policy
  • Cookies
  • Data Protection
  • Sitemap

Research

  • 30 WOUNDCARE
  • 30 RESPIRATORY
  • 30 THERAPEUTICS
  • 30 PHARMA
  • 30 DERMATOLOGY
  • 30 ANIMAL HEALTH

Registered Office

Thirty Holdings Limited
6th Floor, One London Wall
London EC2Y 5EB
United Kingdon

Registered in England
No.11614943

Contact

contact@30.technology
+44 (0) 20 7493 4546

© 30 Technology 2019
All Rights Reserved

Designed by Elegant Themes | Powered by WordPress